Magnetic nanoparticles for targeted cancer diagnosis and therapy

Frontiers of Nanoscience

Volumn 5, Issue , 2013, Pages 29-63

  Williams, Marc J ^a   Corr, Serena A ^b  

^a UNIVERSITY OF KENT   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Contrast agents; Magnetic nanoparticles; Targeted therapies; Theranostic applications

Indexed keywords

CONTROLLED DRUG DELIVERY; DIAGNOSIS; DISEASES; MAGNETIC RESONANCE; NANOMAGNETICS; NANOPARTICLES;

BIOMEDICAL USE; CANCER DIAGNOSIS; CANCER THERAPY; CONTRAST AGENT; DEVELOPMENT AND APPLICATIONS; DISEASE TREATMENT; PROPERTY; TARGETED THERAPY; THERANOSTIC APPLICATION; THERANOSTICS;

TARGETED DRUG DELIVERY;

EID: 84884397349     PISSN: 18762778     EISSN: 1876276X     Source Type: Book Series    
DOI: 10.1016/B978-0-08-098338-7.00002-9     Document Type: Chapter

References (99)

1. Berry C.C., Curtis A.S.G. Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 2003, 36:R198-R206.
2. Pankhurst Q.A., Thanh N.T.K., Jones S.K., Dobson J. Progress in applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2009, 42:224001-1-224001-15.
3. Berry C.C. Progress in functionalization of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 2009, 42:224003-1-224003-9.
4. Lu A.-H., Salabas E.L., Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl 2007, 46:1222-1244.
5. Wang Y.-X.J. Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg 2011, 1:35-40.
6. Corr S.A., Rakovich Y.P., Gun'ko Y.K. Multifunctional magnetic-fluorescent nanocomposites for biomedical applications. Nanoscale Res Lett 2008, 3:87-104.
7. Yoo D., Lee J.-H., Shin T.-H., Cheon J. Theranostic magnetic nanoparticles. Acc Chem Res 2011, 44:863-874.
8. Reddy L.H., Arias J.L., Nicolas J., Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 2012, 112:5818-5878.
9. Kievit F.M., Zhang M. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc Chem Res 2011, 44:853-862.
10. Pankhurst Q.A., Connolly J., Jones S.K., Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2003, 36:R167-R181.
11. Laurent S., Forge D., Port M., Roch A., Robic C., Elst L.V., et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008, 108:2064-2110.
12. Pileni M.-P. Magnetic fluids: fabrication, magnetic properties, and organization of nanocrystals. Adv Funct Mater 2001, 11:323-336.
13. Corr S.A. Metal oxide nanoparticles. Nanoscience 2013, vol. 1:180-207. Royal Society of Chemistry, Paul O'Brien, Cambridge.
14. Chadwick A.V., Savin S.L.P. Metal oxide nanoparticles 2010, John Wiley and Sons, Hoboken, NJ.
15. Rao C.N.R., Matte H.S.S.R., Voggu R., Govindaraj A. Recent progress in the synthesis of inorganic nanoparticles. Dalton Trans 2012, 41:5089-5120.
16. Patzke G.R., Zhou Y., Kontic R., Conrad F. Oxide nanomaterials: synthetic developments, mechanistic studies and technological innovations. Angew Chem Int Ed Engl 2011, 50:826-859.
17. Ladj R., Bitar A., Eissa M., Mugnier Y., Dantec R.L., Fessi H., et al. Individual inorganic nanoparticles: preparation, functionalization and in vitro biomedical diagnostic applications. J Mater Chem B 2013, 1:1381-1396.
18. Roca A.G., Costo R., Rebolledo A.F., Veintemillas-Verdaguer S., Tartaj P., González-Carreño T., et al. Progress in the preparation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 2009, 42:224002-1-224002-11.
19. Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn 1981, 17:1247-1248.
20. Polarz S. Shape matters: anisotropy of the morphology of inorganic colloidal particles-synthesis and function. Adv Funct Mater 2011, 21:3214-3230.
21. 3 nanoparticles and their magnetic properties. Mater Res Bull 2007, 42:1570-1576.
22. Mikhaylova M., Kim D.K., Bobrysheva N., Osmolowsky M., Semenov V., Tsakalakos T., et al. Superparamagnetism of magnetite nanoparticles: dependence on surface modification. Langmuir 2004, 20:2472-2477.
23. 2 core-shell nanoparticles with tunable properties. ACS Nano 2008, 2:847-856.
24. Guardia P., Labarta A., Batlle X. Tuning the size, the shape, and the magnetic properties of iron oxide nanoparticles. J Phys Chem C 2011, 115:390-396.
25. 4 (M=Fe, Co, Mn) nanoparticles: tuning the particle size and magnetic properties through a novel one-step coprecipitation route. Chem Mater 2012, 24:1496-1504.
26. Hyeon T. Chemical synthesis of magnetic nanoparticles. Chem Commun 2003, 8:927-934.
27. Sun S., Zeng H. Size-controlled synthesis of magnetite nanoparticles. J Am Chem Soc 2002, 124:8204-8205.
28. Lee J., Zhang S., Sun S. High-temperature solution-phase syntheses of metal-oxide nanocrystals. Chem Mater 2013, 25:1293-1304.
29. Hyeon T., Lee S.S., Park J., Chung Y., Na H.B. Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chem Soc 2001, 123:12798-12801.
30. Park J., An K., Hwang Y., Park J.-G., Noh H.-J., Kim J.-Y., et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 2004, 3:891-895.
31. Voggu R., Shireen A., Rao C.N.R. One-step synthesis of high-purity fluorous-capped inorganic nanoparticles. Dalton Trans 2010, 39:6021-6023.
32. Carvalho M.D., Henriques F., Ferreira L.P., Godinho M., Cruz M.M. Iron oxide nanoparticles: the influence of synthesis method and size on composition and magnetic properties. J Solid State Chem 2013, 201:144-152.
33. Cai H., An X., Cui J., Li J., Wen S., Li K., et al. Facile hydrothermal synthesis and surface functionalization of polyethyleneimine-coated iron oxide nanoparticles for biomedical applications. ACS Appl Mater Inter 2013, 5:1722-1731.
34. de Tercero M.D., Bruns M., Martínez I.G., Türk M., Fehrenbacher U., Jennewein S., et al. Continuous hydrothermal synthesis of in situ functionalized iron oxide nanoparticles-a general strategy to produce metal oxide nanoparticles presenting clickable anchors. Part Part Syst Charact 2013, 30:229-234.
35. 4/poly(styrene-co-acrylamide) composite nanoparticles prepared by microwave-assisted emulsion polymerization. React Funct Polym 2008, 68:332-339.
36. Corr S.A., Gun'ko Y.K., Douvalis A.P., Venkatesan M., Gunning R.D. Magnetite nanocrystals from a single source metallorganic precursor: metallorganic chemistry vs biogeneric bacteria. J Mater Chem 2004, 14:944-946.
37. Komarneni S., D'Arrigo M.C., Leonelli C., Pellacani G.C., Katsuki H. Microwave-hydrothermal synthesis of nanophase ferrites. J Am Ceram Soc 1998, 81:3041-3043.
38. Tassa C., Shaw S.Y., Weissleder R. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res 2011, 44:842-852.
39. Guerrero-Martínez A., Pérez-Juste J., Liz-Marzán L.M. Recent progress on silica coating of nanoparticles and related nanomaterial. Adv Mater 2010, 22:1182-1195.
40. Chen D., Jiang M., Li N., Gu H., Xu Q., Ge J., et al. Modification of magnetic silica/iron oxide nanocomposites with fluorescent polymethacrylic acid for cancer targeting and drug delivery. J Mater Chem 2010, 20:6422-6429.
41. Chen Y., Chen H., Zhang S., Chen F., Zhang L., Zhang J., et al. Multifunctional mesoporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs. Adv Funct Mater 2011, 21:270-278.
42. Philipse A.P., van Bruggen M.P.B., Pathmamanoharan C. Magnetic silica dispersions: preparation and stability of surface-modified silica particles with a magnetic core. Langmuir 1994, 10(1):92-99.
43. McCarthy S.A., Davies G.-L., Gun'ko Y.K. Preparation of multifunctional nanoparticles and their assemblies. Nat Protoc 2012, 7:1677-1693.
44. Xie J., Liu G., Eden H.S., Ai H., Chen X. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res 2011, 44:883-892.
45. Brigger I., Dubernet C., Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002, 54:631-651.
46. Stubbs M., McSheehy P.M.J., Griffiths J.R., Bashford C.L. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 2000, 6:15-19.
47. Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater 2009, 21:2133-2148.
48. Muller R.N., Roch A., Colet J.-M., Ouakssim A., Gillis P. Particulate magnetic contrast agents. The chemistry of contrast agents in medical magnetic resonance imaging 2001, 417-435. John Wiley and Sons, New York. A.E. Merbach, E. Toth (Eds.).
49. Ghosh S., Carty D., Clarke S.P., Corr S.A., Tekoriute R., Gun'ko Y.K., et al. NMR studies into colloidal stability and magnetic order in fatty acid stabilised aqueous magnetic fluids. Phys Chem Chem Phys 2010, 12:14009-14016.
50. Corr S.A., Gun'ko Y.K., Tekoriute R., Meledandri C.J., Brougham D.F. Poly(sodium-4-styrene)sulfonate-iron-oxide nanocomposite dispersions with controlled magnetic resonance properties. J Phys Chem C 2008, 112:13324-13327.
51. 2 contrast agent. Adv Mater 2007, 19:1874-1878.
52. Byrne S.J., Corr S.A., Gun'ko Y.K., Kelly J.M., Brougham D.F., Ghosh S. Magnetic nanoparticle assemblies on denatured DNA show unusual magnetic relaxivity and potential applications for MRI. Chem Commun 2004, 22:2560-2561.
53. Corr S.A., Byrne S.J., Tekoriute R., Meledandri C.J., Brougham D.F., Lynch M., et al. Linear assemblies of magnetic nanoparticles as MRI contrast agents. J Am Chem Soc 2008, 130:4214-4215.
54. Gallagher J.J., Tekoriute R., O'Reilly J.-A., Kerskens C., Gun'ko Y.K., Lynch M. Bimodal magnetic-fluorescent nanostructures for biomedical applications. J Mater Chem 2009, 19:4081-4084.
55. Chertok B., David A.E., Yang V.C. Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials 2010, 31:6317-6324.
56. Wang Y.-X.J., Hussain S.M., Krestin G.P. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001, 11:2319-2331.
57. 4 nanocrystals with precise size control of one nanometre as potential MRI contrast agents. J Mater Chem 2011, 21:2476-2481.
58. Lee N., Kim H., Choi S.H., Park M., Kim D., Kim H.-C., et al. Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets. PNAS 2011, 108:2662-2667.
59. 2 relaxivity for highly sensitive in vivo MRI of tumors. Nano Lett 2012, 12:3127-3131.
60. Boyer C., Whittaker M.R., Bulmus V., Liu J., Davis T.P. The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications. NPG Asia Mater 2010, 2:23-30.
61. Singh N., Jenkins G.J.S., Asadi R., Doak S.H. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 2010, 1:5358-1-5358-15.
62. Maity D., Zoppellaro G., Sedenkova V., Tucek J., Safarova K., Polakova K., et al. Surface design of core-shell superparamagnetic iron oxide nanoparticles drives record relaxivity values in functional MRI contrast agents. Chem Commun 2012, 48:11398-11400.
63. Na H.B., Palui G., Rosenberg J.T., Ji X., Grant S.C., Mattoussi H. Multidentate catechol-based polyethylene glycol oligomers provide enhanced stability and biocompatibility to iron oxide nanoparticles. ACS Nano 2012, 6:389-399.
64. Lee H.-Y., Lee S.-H., Xu C., Xie J., Lee J.-H., Wu B., et al. Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent. Nanotechnology 2008, 19:165101-1-165101-6.
65. Huang J., Bu L., Xie J., Chen K., Cheng Z., Li X., et al. Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano 2010, 4:7151-7160.
66. Li Z., Yi P.W., Sun Q., Lei H., Zhao H.L., Zhu Z.H., et al. Ultrasmall water-soluble and biocompatible magnetic iron oxide nanoparticles as positive and negative dual contrast agents. Adv Funct Mater 2012, 22:2387-2393.
67. Kim H., Dae H.-M., Park C., Kim E.O., Kim D., Kim I.-H., et al. A highly sensitive magnetite nanoparticle as a simple and rapid stem cell labelling agent for MRI tracking. J Mater Chem 2011, 21:7742-7747.
68. Sandiford L., Phinikaridou A., Protti A., Meszaros L.K., Cui X., Yan Y., et al. Bisphosphonate-anchored PEGylation and radiolabeling of superparamagnetic iron oxide: long-circulating nanoparticles for in vivo multimodal (T1 MRI-SPECT) imaging. ACS Nano 2013, 7(1):500-512.
69. 99m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging. Bioconjug Chem 2011, 22(3):455-465.
70. Shubayev V.I., Pisanic T.R., Jin S. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 2009, 61:467-477.
71. McCarthy J.R., Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008, 60:1241-1251.
72. 4/chitosan nanocomposite for magnetic drug targeting to cancer. J Mater Chem 2012, 22:7622-7632.
73. Cole A.J., David A.E., Wang J., Galbán C.J., Hill H.L., Yang V.C. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials 2011, 32:2183-2193.
74. Plassat V., Wilhelm C., Marsaud V., Ménager C., Gazeau F., Renoir J.-M., et al. Anti-estrogen-loaded superparamagnetic liposomes for intracellular magnetic targeting and treatment of breast cancer tumors. Adv Funct Mater 2011, 21:83-92.
75. Sun C., Du K., Fang C., Bhattarai N., Veiseh O., Kievit F., et al. PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. ACS Nano 2010, 4:2402-2410.
76. Hu S.-H., Chen Y.-Y., Liu T.-C., Tung T.-H., Liu D.-M., Chen S.-Y. Remotely nano-rupturable yolk/shell capsules for magnetically-triggered drug release. Chem Commun 2011, 47:1776-1778.
77. Hwu J.R., Lin Y.S., Josephrajan T., Hsu M.-H., Cheng F.-Y., Yeh C.-S., et al. Targeted paclitaxel by conjugation to iron oxide and gold nanoparticles. J Am Chem Soc 2009, 131:66-68.
78. Cho H.-S., Dong Z., Pauletti G.M., Zhang J., Xu H., Gu H., et al. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment. ACS Nano 2010, 4:5398-5404.
79. Hua M.-Y., Yang H.-W., Chuang C.-K., Tsai R.-Y., Chen W.-J., Chuang K.-L., et al. Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer. Biomaterials 2010, 31:7355-7363.
80. Dilnawaz F., Singh A., Mohanty C., Sahoo S.K. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials 2010, 31:3694-3706.
81. Lee J.E., Lee N., Kim H., Kim J., Choi S.H., Kim J.H., et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J Am Chem Soc 2010, 132:552-557.
82. Lee J., Kim H., Kim S., Lee L., Kim J., Kim N., et al. A multifunctional mesoporous nanocontainer with an iron oxide core and a cyclodextrin gatekeeper for an efficient theranostic platform. J Mater Chem 2012, 22:14061-14067.
83. Zhang F., Braun G.B., Pallaoro A., Zhang Y., Shi Y., Cui D., et al. Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy. Nano Lett 2012, 12:61-67.
84. 2@polyacrylic acid core-shell nanocomposites for cell imaging and pH-responsive drug delivery. Nanoscale 2013, 5:2249-2253.
85. 2 hollow mesoporous spheres for targeted anticancer drug delivery. J Phys Chem C 2010, 114:16382-16388.
86. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel A.E., et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2:889-896.
87. Wu H., Liu G., Zhang S., Shi J., Zhang L., Chen Y., et al. Biocompatibility, MR imaging and targeted drug delivery of a rattle-type magnetic mesoporous silica nanosphere system conjugated with PEG and cancer-cell-specific ligands. J Mater Chem 2011, 21:3037-3045.
88. Kaaki K., Hervé-Aubert K., Chiper M., Shkilnyy A., Soucé M., Benoit R., et al. Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting. Langmuir 2012, 28:1496-1505.
89. Maeng J.H., Lee D.-H., Jung K.H., Bae Y.-H., Park I.-S., Jeong S., et al. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials 2010, 31:4995-5006.
90. Wang F., Chen X., Zhao Z., Tang S., Huang X., Lin C., et al. Synthesis of magnetic, fluorescent and mesoporous core-shell-structured nanoparticles for imaging, targeting and photodynamic therapy. J Mater Chem 2011, 21:11244-11252.
91. Hu J., Qian Y., Wang X., Liu T., Liu S. Drug-loaded and superparamagnetic iron oxide nanoparticle surface-embedded amphiphilic block copolymer micelles for integrated chemotherapeutic drug delivery and MR imaging. Langmuir 2012, 28:2073-2082.
92. Ren T., Liu Q., Lu H., Liu H., Zhang X., Du J. Multifunctional polymer vesicles for ultrasensitive magnetic resonance imaging and drug delivery. J Mater Chem 2012, 22:12329-12338.
93. Yang X., Grailer J.J., Rowland I.J., Javadi A., Hurley S.A., Matson V.Z., et al. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anti-cancer drug delivery and ultrasensitive MR imaging. ACS Nano 2010, 4:6805-6817.
94. Majd M.H., Asgari D., Barar J., Valizadeh H., Kalfil V., Abadpour A., et al. Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer. Colloids Surf B 2013, 106:117-125.
95. di Corato R., Bigal N.C., Ragusa A., Dorfs D., Genovese A., Marotta R., et al. Multifunctional nanobeads based on quantum dots and magnetic nanoparticles: synthesis and cancer cell targeting and sorting. ACS Nano 2011, 5:1109-1121.
96. Yang S., Chen D., Li N., Mei X., Qi X., Li H., et al. J Mater Chem 2012, 22:25345-25361.
97. Zhao Z., Huang D., Yin Z., Chi X., Wang X., Gao J. J Mater Chem 2012, 22:15717-15725.
98. Foy S.P., Manthe R.L., Foy S.T., Dimitrijevic S., Krishnamurthy N., Labhasetwar V. Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. ACS Nano 2010, 4:5217-5224.
99. Lee G.Y., Qian W.P., Wang L., Wang Y.A., Staley C.A., Satpathy M., et al. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. ACS Nano 2013, 7:2078-2089.